home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

58.15 -2.27 (-3.77%)

Streaming Delayed Price Updated: 12:43 PM EDT, Jun 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Moderna Shares Are Up Today: What's Going On? ↗

January 23, 2025

Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment.

Via Benzinga

Topics Artificial Intelligence

Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines ↗

January 22, 2025

Ellison, Oracle's chairman, pointed to the use of AI to develop drugs like Moderna's cancer vaccine.

Via Investor's Business Daily

Topics Artificial Intelligence

These 3 Stocks Are Down to Start 2025. What's Going On? ↗

January 22, 2025

Sonos, Moderna, and Shake Shack are all staring at some near-term headwinds – can they work through them?

Via The Motley Fool

Moderna Unusual Options Activity For January 22 ↗

January 22, 2025

Via Benzinga

Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday ↗

January 22, 2025

Via Benzinga

Why Is Moderna Stock Trading Higher On Tuesday? ↗

January 21, 2025

Moderna secures $590 million from HHS for mRNA flu vaccine development.

Via Benzinga

Where Will Moderna Be in 3 Years? ↗

January 21, 2025

Via The Motley Fool

After a Reset Year, Is Moderna Stock Poised for a Comeback?

January 22, 2025

Moderna had a rough 2024 and is starting 2025 with lowered forecasts, but is focused on getting 10 FDA approvals in the next three years. Is now time to buy?

Via MarketBeat

Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine ↗

January 21, 2025

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus.

Via Benzinga

Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under Trump ↗

January 21, 2025

In 2023, Moderna initiated a Phase 1/2 study to assess the safety and immunogenicity of its investigational bird flu vaccine, mRNA-1018, in healthy adults aged 18 and older.

Via Stocktwits

Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday ↗

January 21, 2025

Via Benzinga

Is Moderna Stock a Buy? ↗

January 19, 2025

Via The Motley Fool

Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now? ↗

January 16, 2025

Via The Motley Fool

3M, Netflix And 3 Stocks To Watch Heading Into Tuesday ↗

January 21, 2025

US stock futures trading higher on Tuesday. Stocks to watch: 3M, D.R. Horton, Moderna, United Airlines, Netflix.

Via Benzinga

Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio? ↗

January 19, 2025

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,...

Via Benzinga

These Were the 5 Worst-Performing Stocks in the S&P 500 in 2024 ↗

January 18, 2025

Via The Motley Fool

Topics Stocks

Moderna Announces Updates on Pandemic Influenza Program

January 17, 2025

Via ACCESS Newswire

Is Moderna a Bad-News Buy for 2025? ↗

January 16, 2025

Via The Motley Fool

Down 79%, Is Moderna Stock a Bad-News Buy on the Dip? ↗

January 16, 2025

Via The Motley Fool

Moderna Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) ↗

January 15, 2025

Via Benzinga

Is Moderna Stock a No-Brainer Buy on the Sell-Off? ↗

January 15, 2025

Via The Motley Fool

Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review ↗

January 17, 2025

Many stocks flashed buy signals as the major indexes rose to or above key levels.

Via Investor's Business Daily

Topics Economy

Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks ↗

January 17, 2025

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with unknowns.

Via Investor's Business Daily

Topics Government

Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing ↗

January 16, 2025

The CDC issued a health advisory Thursday recommending that hospitalized patients who have tested positive for influenza be tested for the bird flu virus within 24 hours.

Via Benzinga

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell? ↗

January 14, 2025

Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025.

Via Investor's Business Daily

Moderna Stock Takes A 20% Hit ↗

January 13, 2025

Moderna stock is now down close to 30% versus its YTD high.

Via Talk Markets

Topics Stocks / Equities

Why Moderna Stock Just Crashed 21% ↗

January 13, 2025

Via The Motley Fool

Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday? ↗

January 13, 2025

Traders adopted a cautious approach on Monday as they awaited two critical inflation reports due later this week, seeking clarity on Federal Reserve interest rate policy.

Via Benzinga

Topics Economy

Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge ↗

January 13, 2025

Via Benzinga

Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge ↗

January 13, 2025

Via Benzinga

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com